Xiaoxianxiong decoction attenuates diabetes-associated cognitive decline in db/db mice by modulating microglial iron overload and neuroinflammation
World Journal of Diabetes · 16.11.2026
DOI: 10.4239/wjd.124571 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 16.11.2026. Verfasst von Zhi Zhang und 9 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUNDDiabetes-associated cognitive decline (DACD) is a common complication of type 2 diabetes mellitus that is characterized by neuroinflammation.Emerging evidence suggests that iron overload in hippocampal microglia exacerbates neuroinflammatory responses, contributing to cognitive decline. AIMTo investigate whether Xiaoxianxiong decoction (XXD), a traditional Chinese herbal formula, can alleviate DACD by regulating microglial iron homeostasis. METHODSSince DACD involves complex neuroinflammation, we used db/db mice as a type 2 diabetes mellitus model.XXD was administered at low, medium, and high doses, and liraglutide served as a positive control.Behavioural testing, proteomics, and molecular assays were performed.Moreover, cell-based experiments were conducted to evaluate the effects of XXD on neuroinflammation, iron metabolism, and microglial polarization. RESULTSXXD significantly improved glucose metabolism, spatial memory, and hippocampal synaptic integrity in db/db mice.Furthermore, XXD reduced hippocampal iron accumulation, downregulated transferrin receptor 1 (TFR1) expression, and shifted microglial polarization from the proinflammatory M1 phenotype to the antiinflammatory M2 phenotype.In vitro studies using Bv2 microglia cultured under highglucose conditions confirmed that XXD-mediated TFR1 inhibition alleviated iron overload, oxidative stress, and inflammatory cytokine release.The molecular docking 4 / 53 analysis revealed that the brain-penetrating components of XXD have high affinity for TFR1. CONCLUSIONThese findings suggest that XXD may alleviate DACD through the regulation of microglial iron uptake by TFR1, thereby reducing neuroinflammation and promoting neuronal recovery.This study provides new insights into the neuromodulatory effects of XXD and supports its potential as a therapeutic strategy for DACD that may be accompanied by abnormalities in iron metabolism and inflammation.
Zitieren
APA
Zhang, Z., Gao, X., Tang, M., An, G., Yang, G., Zhao, M., Liu, X., Yang, Z., An, J., & Zhao, Y. (2026). Xiaoxianxiong decoction attenuates diabetes-associated cognitive decline in db/db mice by modulating microglial iron overload and neuroinflammation. World Journal of Diabetes. https://doi.org/10.4239/wjd.124571
Vancouver
Zhang Z, Gao X, Tang M, An G, Yang G, Zhao M, et al. Xiaoxianxiong decoction attenuates diabetes-associated cognitive decline in db/db mice by modulating microglial iron overload and neuroinflammation. World Journal of Diabetes. 2026. doi:10.4239/wjd.124571
BibTeX
@article{Zhang2026,
author = {Zhang, Zhi and Gao, Xiao-Meng and Tang, Miao and An, Guo-Tao and Yang, Guo-Shuang and Zhao, Min and Liu, Xiao-Jie and Yang, Zhuo-Zhan and An, Ji-Ren and Zhao, Ya-Shuo},
title = {Xiaoxianxiong decoction attenuates diabetes-associated cognitive decline in db/db mice by modulating microglial iron overload and neuroinflammation},
journal = {World Journal of Diabetes},
year = {2026},
doi = {10.4239/wjd.124571}
}
EUVIMED